Skip main navigation
You are at: Home>The Association>UNE Information Room>News>Survey measuring the quality of life of patients suffering from multiple sclerosis

Highlights

Survey
News

Survey measuring the quality of life of patients suffering from multiple sclerosis

24/07/2019

The Spanish Association for Standardization, UNE, participates in the research and Innovation programme Optogenerapy, within the framework of the EU Research and Innovation programme Horizon 2020.

The aim of this project is to develop a new optogenetic implant to improve the quality of life of patients suffering from multiple sclerosis. This project develops a technology to automate treatment for multiple sclerosis by means of a subcutaneous implant. Optogenetics is the combination of genetic and optical methods to stimulate or inhibit well-defined events in specific cells of living tissue.

To know the potential value of the implant, it is important to understand the real quality of life of these patients. Hence, a questionnaire has been drawn up aimed at patients suffering from multiple sclerosis who would like to contribute to the goal of the project.

The project, as well as using standards, aims to publish a regulatory agreement (CWA) by the European Standardisation Committee (CEN) that includes part of the research results, thus contributing to its dissemination among the scientific and technical community of the CEN.

The project contributes to the achievement of the SDG 3 Health and Wellbeing.

UNE is a regular participant in EU R&D&I projects, with over 60 interventions, especially in Horizon 2020. This public funding programme aims to ensure that activities are not limited to the scientific field, but also provide an effective response to other European issues. UNE participation and the use of standards contributes to the success of these projects.

To take part in the survey, use one of these 5 languages: English, French, German, Italian and Dutch.